Amylyx Pharmaceuticals Financial Statements From 2010 to 2024
| AMLX Etf | USD 5.34 0.15 2.89% |
Gross Profit -74.2 M | Profit Margin (1.32) | Market Capitalization 355.8 M | Enterprise Value Revenue 0.6308 | Revenue 196.5 M |
Check Amylyx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amylyx Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Amylyx financial statements analysis is a perfect complement when working with Amylyx Pharmaceuticals Valuation or Volatility modules.
Amylyx |
Amylyx Pharmaceuticals ETF Price To Book Analysis
Amylyx Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Amylyx Pharmaceuticals Price To Book | 1.81 X |
Most of Amylyx Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amylyx Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Amylyx Pharmaceuticals has a Price To Book of 1.8132 times. This is much higher than that of the Pharmaceuticals family and significantly higher than that of the Health Care category. The price to book for all United States etfs is notably lower than that of the firm.
Amylyx Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amylyx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Amylyx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amylyx Pharmaceuticals competition to find correlations between indicators driving Amylyx Pharmaceuticals's intrinsic value. More Info.Amylyx Pharmaceuticals is fifth largest ETF in price to book as compared to similar ETFs. It is rated below average in price to sales as compared to similar ETFs fabricating about 1.00 of Price To Sales per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amylyx Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Amylyx Pharmaceuticals Financial Statements
Amylyx Pharmaceuticals investors use historical fundamental indicators, such as Amylyx Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amylyx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.